Stallergenes
   HOME

TheInfoList



OR:

Stallergenes Greer International AG is a global bio
pharmaceutical company The pharmaceutical industry is a Medicine, medical industry that discovers, develops, produces, and markets pharmaceutical goods such as medications and medical devices. Medications are then administered to (or Self-medicate, self-administered b ...
headquartered in Baar, Switzerland, specializing in the diagnosis and treatment of allergies through
allergen immunotherapy Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies (such as insect bites) and asthma. Immunotherapy involves exposing people to larger and larger amounts of allergens ...
. Stallergenes Greer International AG is the parent company of Greer Laboratories, Inc. (registered office in the U.S.) and Stallergenes S.A.S. (registered office in France). With 1129 employees in 2023, Stallergenes Greer operates in 21 countries and 44 countries including the distribution network. Stallergenes Greer's core manufacturing facilities are located both in Europe ( Antony and Amilly in France), in the
USA The United States of America (USA), also known as the United States (U.S.) or America, is a country primarily located in North America. It is a federal republic of 50 states and a federal capital district, Washington, D.C. The 48 contiguous ...
(
Lenoir, NC Lenoir ( ) is a city in and the county seat of Caldwell County, North Carolina, United States. The population was 18,263 at the 2020 census. Lenoir is located in the foothills of the Blue Ridge Mountains. To the northeast are the Brushy Mounta ...
; Mathiston, MI; and
San Diego, CA San Diego ( , ) is a city on the Pacific coast of Southern California, adjacent to the Mexico–United States border. With a population of over 1.4 million, it is the List of United States cities by population, eighth-most populous city in t ...
), and in Canada ( Dutton, ON).


History

Stallergenes was founded in 1962 by Institut Mérieux In 2015, Stallergenes and Greer Laboratories Inc. merged to form Stallergenes Greer, "a worldwide leader in allergy immunotherapy". Greer was founded by R.T. Greer, a collector of source materials (i.e.: roots, herbs, pollens) in 1904. Stallergenes Greer is a privately held company owned by B-Flexion (ex Waypoint Capital), chaired by Ernesto Bertarelli.


Activity

Stallergenes Greer is specialised in allergy immunotherapy treatments. It includes Name Patient Products (NPP) which are allergen products, prepared in accordance with prescriptions for individual patients. The product portfolio covers different segments including sublingual products (Staloral®,
Oralair Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies (such as insect bites) and asthma. Immunotherapy involves exposing people to larger and larger amounts of allergens i ...
®, Actair®), subcutaneous products (Alustal®/Albey®), oral immunotherapy (Palforzia), allergen extracts available as a bulk extract or NPP, veterinary products, testing supplies, source materials and other supplies like sterile diluents, sterile empty vials.


Governance

The board of directors includes: *Cyrus Jilla, chairman *Michele Antonelli *Giampero De Luca *Nithya Desikan *Ranjani Kearsley *Andreas Amrein, chief executive officer


A pharmaceutical and clinical development programme

Since 2003, Stallergenes has been involved in a clinical development programme whose objective is to develop proprietary medicines intended to cover the main allergens responsible for more than 80% of respiratory allergies.
Oralair Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies (such as insect bites) and asthma. Immunotherapy involves exposing people to larger and larger amounts of allergens i ...
is the first sublingual
immunotherapy Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as ''activation immunotherapies,'' while immunotherap ...
tablet resulting from this programme.
Oralair Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies (such as insect bites) and asthma. Immunotherapy involves exposing people to larger and larger amounts of allergens i ...
is marketed in 22 countries and has been approved by the
Food and Drug Administration The United States Food and Drug Administration (FDA or US FDA) is a List of United States federal agencies, federal agency of the United States Department of Health and Human Services, Department of Health and Human Services. The FDA is respo ...
in the United States. The second project in this programme is the house
dust mite House dust mites (HDM, or simply dust mites) are various species of acariform mites belonging to the family Pyroglyphidae that are found in association with dust in dwellings. They are known for causing allergies. Biology Species The current ...
immunotherapy tablet Actair which is marketed in
Japan Japan is an island country in East Asia. Located in the Pacific Ocean off the northeast coast of the Asia, Asian mainland, it is bordered on the west by the Sea of Japan and extends from the Sea of Okhotsk in the north to the East China Sea ...
,
Australia Australia, officially the Commonwealth of Australia, is a country comprising mainland Australia, the mainland of the Australia (continent), Australian continent, the island of Tasmania and list of islands of Australia, numerous smaller isl ...
, and
New Zealand New Zealand () is an island country in the southwestern Pacific Ocean. It consists of two main landmasses—the North Island () and the South Island ()—and List of islands of New Zealand, over 600 smaller islands. It is the List of isla ...
, and South Korea under the brand name Actair and in Germany under the brand name Orylmyte. In 2021, Stallergenes Greer is partnering with Aptar Pharma to develop a novel connected device for allergen immunotherapy treatment delivery. It will contribute to improving adherence, thus optimising treatment outcomes.


References


External links

* {{Authority control Pharmaceutical companies of France Allergology Pharmaceutical companies of the United Kingdom Companies based in Île-de-France